Abiopharma

🔍 MAULDIN MARK D (Executive)

Company: SILICON LABORATORIES INC. (SLAB)

Report Date: 2026-04-30

Detailed Transactions and Holdings:

• Acquired 18 shares of Common Stock, $0.0001 par value at $86.46 per share (Direct)
  Date: 2026-04-30 | Code: A | equity_swap_involved: 0 | shares_owned_after: 21,948.00 | transaction_form_type: 5 | Footnotes: F1

Footnotes:

• F1: Shares acquired by Reporting Person through the Issuer's 2009 Employee Stock Purchase Plan on the most recent semi-annual purchase date in a transaction exempt under both Rule 166-3(c) and Rule 166-3(d).